The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Accepteret manuskript, 2,51 MB, PDF-dokument
Originalsprog | Engelsk |
---|---|
Tidsskrift | The Lancet Gastroenterology and Hepatology |
Vol/bind | 8 |
Udgave nummer | 5 |
Sider (fra-til) | 458-492 |
Antal sider | 35 |
ISSN | 2468-1253 |
DOI | |
Status | Udgivet - 2023 |
Bibliografisk note
Funding Information:
Figure 1 was created with the aid of a grant (number G-2108-04777) from The Leona M and Harry B Helmsley Charitable Trust.
Funding Information:
Rates of participation in the audit process increased from around 76% in the first audit round to more than 95% by the end of the process. How was this done? Each hospital had a lead clinician to take responsibility and the Chief Executive of the hospital was kept informed of the process. The teams were engaged throughout the process with regular feedback, and involvement of the national charity and gastroenterology society ensured widespread dissemination of its results. The programme initially received funding from the Health Foundation, followed later by NHS funding of around £2 million over the 12-year project, equating to around £115 per patient in the audit. The initiative has been adopted by other countries such as the Netherlands, Australia, and New Zealand.
Publisher Copyright:
© 2023 Elsevier Ltd
ID: 397791895